晚期或难治性实体恶性肿瘤的临床试验
总计3583个结果
-
TakedaTakeda Development Center Americas, Inc.主动,不招人晚期或转移性实体瘤美国, 中国, 克罗地亚, 日本, 拉脱维亚, 波兰, 巴西, 立陶宛, 瑞士
-
Shijiazhuang Yiling Pharmaceutical Co. LtdTigermed Consulting Co., Ltd未知
-
Merck KGaA, Darmstadt, Germany完全的
-
Gustave Roussy, Cancer Campus, Grand Paris完全的
-
Aptose Biosciences Inc.完全的
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...招聘中
-
Cornerstone Pharmaceuticals完全的
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.招聘中
-
Avistone Biotechnology Co., Ltd.Zhejiang Cancer Hospital; Henan Cancer Hospital; Hunan Cancer Hospital; Peking University Cancer... 和其他合作者招聘中
-
Pierre Fabre Medicament终止
-
OncoMed Pharmaceuticals, Inc.Celgene Corporation完全的
-
Shanghai Miracogen Inc.招聘中
-
Amsterdam UMC, location VUmc终止Advanced or Metastatic Solid Malignancy荷兰
-
Jiangsu HengRui Medicine Co., Ltd.307 Hospital of PLA; Peking University Cancer Hospital & Institute完全的
-
ArQule, Inc. (a wholly owned subsidiary of Merck...完全的
-
Merck Sharp & Dohme LLCAstraZeneca完全的
-
Sameek Roychowdhury主动,不招人
-
Shanghai Yuyao Biotech Co., Ltd.招聘中
-
Dong-A ST Co., Ltd.尚未招聘
-
Chinese PLA General HospitalWuxi Sinotide New Drug Discovery Institutes招聘中
-
Antengene Therapeutics LimitedMerck Sharp & Dohme LLC招聘中
-
Shanghai East HospitalImbioray (Hangzhou) Biomedicine Co., Ltd.招聘中